These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 16182822

  • 21. Conversion of cyclosporine to sirolimus before 12 months is associated with marked improvement in renal function and low proteinuria in a South African renal transplant population.
    Maharaj S, Assounga AG.
    Exp Clin Transplant; 2010 Mar; 8(1):14-8. PubMed ID: 20199366
    [Abstract] [Full Text] [Related]

  • 22. Different profile of gene expression of cytokines in peripheral blood mononuclear cells of transplant recipients treated with m-TOR inhibitor and calcineurin inhibitor.
    Niemczyk M, Zegarska J, Pawłowska M, Wyzgał J, Ciszek M, Paczek L.
    Transpl Immunol; 2009 Jan; 20(3):139-42. PubMed ID: 18834941
    [Abstract] [Full Text] [Related]

  • 23. Factors influencing glomerular filtration rate in renal transplantation after cyclosporine withdrawal using sirolimus-based therapy: a multivariate analysis of results at five years.
    Legendre C, Brault Y, Morales JM, Oberbauer R, Altieri P, Riad H, Mahony J, Messina M, Pussell B, Martínez JG, Lelong M, Burke JT, Neylan JF, Rapamune Maintenance Regimen Study Group.
    Clin Transplant; 2007 Jan; 21(3):330-6. PubMed ID: 17488381
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Use of Sirolimus in five pediatric patients undergoing solid organ transplantation].
    Roque E J, Ríos M G, Vignolo A P, Pinochet V C, Schultz M, Humeres A R, Delucchi A, Rius A M, Hepp K J.
    Rev Med Chil; 2008 May; 136(5):631-6. PubMed ID: 18769812
    [Abstract] [Full Text] [Related]

  • 29. Renal function in renal or liver transplant recipients after conversion from a calcineurin inhibitor to sirolimus.
    Bäckman L, Reisaeter AV, Wramner L, Ericzon BG, Salmela K, Brattström C.
    Clin Transplant; 2006 May; 20(3):336-9. PubMed ID: 16824151
    [Abstract] [Full Text] [Related]

  • 30. Sirolimus in pediatric renal transplantation.
    Ibáñez JP, Monteverde ML, Goldberg J, Diaz MA, Turconi A.
    Transplant Proc; 2005 Mar; 37(2):682-4. PubMed ID: 15848500
    [Abstract] [Full Text] [Related]

  • 31. Evaluation of the efficacy and safety of conversion to sirolimus in 85 renal transplant recipients.
    Sola E, Lopez V, Gutierrez C, Cabello M, Burgos D, Gonzalez Molina M, Hernandez D.
    Transplant Proc; 2009 Mar; 41(6):2137-8. PubMed ID: 19715855
    [Abstract] [Full Text] [Related]

  • 32. Sirolimus therapy in liver transplant patients: an initial experience at a single center.
    Nocera A, Andorno E, Tagliamacco A, Morelli N, Bottino G, Ravazzoni F, Casaccia M, Barocci S, Alice S, Santori G, Ghirelli R, Valente U.
    Transplant Proc; 2008 Mar; 40(6):1950-2. PubMed ID: 18675098
    [Abstract] [Full Text] [Related]

  • 33. Increase of proteinuria after conversion from calcineurin inhibitor to sirolimus-based treatment in kidney transplant patients with chronic allograft dysfunction.
    Ruiz JC, Campistol JM, Sánchez-Fructuoso A, Rivera C, Oliver J, Ramos D, Campos B, Arias M, Diekmann F.
    Nephrol Dial Transplant; 2006 Nov; 21(11):3252-7. PubMed ID: 16954170
    [Abstract] [Full Text] [Related]

  • 34. Conversion to sirolimus-based immunosuppression in maintenance liver transplantation patients.
    Morard I, Dumortier J, Spahr L, Hadengue A, Majno P, Morel P, Mentha G, Giostra E.
    Liver Transpl; 2007 May; 13(5):658-64. PubMed ID: 17457887
    [Abstract] [Full Text] [Related]

  • 35. A randomized controlled trial of late conversion from calcineurin inhibitor (CNI)-based to sirolimus-based immunosuppression in liver transplant recipients with impaired renal function.
    Watson CJ, Gimson AE, Alexander GJ, Allison ME, Gibbs P, Smith JC, Palmer CR, Bradley JA.
    Liver Transpl; 2007 Dec; 13(12):1694-702. PubMed ID: 18044728
    [Abstract] [Full Text] [Related]

  • 36. Sirolimus in chronic allograft nephropathy in pediatric recipients.
    Ibáñez JP, Monteverde ML, Diaz MA, Goldberg J, Turconi AF.
    Pediatr Transplant; 2007 Nov; 11(7):777-80. PubMed ID: 17910656
    [Abstract] [Full Text] [Related]

  • 37. Conversion to sirolimus from cyclosporine may induce nephrotic proteinuria and progressive deterioration of renal function in chronic allograft nephropathy patients.
    Boratyńska M, Banasik M, Watorek E, Falkiewicz K, Patrzałek D, Szyber P, Klinger M.
    Transplant Proc; 2006 Nov; 38(1):101-4. PubMed ID: 16504675
    [Abstract] [Full Text] [Related]

  • 38. Conversion to sirolimus in renal transplant patients with tumors.
    Sánchez-Fructuoso A, Conesa J, Perez Flores I, Ridao N, Calvo N, Prats D, Rodríguez A, Barrientos A.
    Transplant Proc; 2006 Oct; 38(8):2451-2. PubMed ID: 17097964
    [Abstract] [Full Text] [Related]

  • 39. Evaluation of the efficacy and safety of a slow conversion from calcineurin inhibitor- to sirolimus-based therapies in maintenance renal-transplant patients presenting with moderate renal insufficiency.
    Kamar N, Frimat L, Blancho G, Wolff P, Delahousse M, Rostaing L.
    Transpl Int; 2007 Feb; 20(2):128-34. PubMed ID: 17239020
    [Abstract] [Full Text] [Related]

  • 40. Accuracy and variability of equations to estimate glomerular filtration rates in renal transplant patients receiving sirolimus and/or calcineurin inhibitor immunosuppression.
    Burke JT, Brault Y, Kahan BD, Hricik DE, Grinyó JM, Chapman JR, Polinsky M, Neylan JF.
    Transpl Int; 2008 May; 21(5):434-40. PubMed ID: 18194393
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.